Criteria

American Joint Committee on Cancer (AJCC) TNM staging system (8th edition)[1]

The AJCC staging system describes the extent of disease based on the following anatomical factors: size and extent of the primary tumour (T); regional lymph node involvement (N) (assessed clinically [cN] and pathologically [pN]); and presence or absence of distant metastases (M). Non-anatomical prognostic factors (e.g., tumour grade, biomarkers [hormone-receptor status and HER2 status]) can be used to supplement staging.

Use of this content is subject to our disclaimer